Educating Parents About Meningococcal Disease
Pfizer has partnered with The Kimberly Coffey Foundation on a National Meningococcal Disease Awareness Survey to better understand parents’ knowledge of meningococcal disease and available vaccines.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care
Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.
'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care
Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
Behind the Science: Breaking the Cycle of C. difficile
The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing! Clostridioides difficile, also known as C. difficile, is one such bacterium.
'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care
Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.
'Science Has Kept Me Here': How Biomarker Research is Shaping the Future of Cancer Care
Debbie Pickworth shares her journey and experience after receiving a lung cancer diagnosis.
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.